BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29875355)

  • 1. Oxidation-specific epitopes restrain bone formation.
    Ambrogini E; Que X; Wang S; Yamaguchi F; Weinstein RS; Tsimikas S; Manolagas SC; Witztum JL; Jilka RL
    Nat Commun; 2018 Jun; 9(1):2193. PubMed ID: 29875355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.
    Que X; Hung MY; Yeang C; Gonen A; Prohaska TA; Sun X; Diehl C; Määttä A; Gaddis DE; Bowden K; Pattison J; MacDonald JG; Ylä-Herttuala S; Mellon PL; Hedrick CC; Ley K; Miller YI; Glass CK; Peterson KL; Binder CJ; Tsimikas S; Witztum JL
    Nature; 2018 Jun; 558(7709):301-306. PubMed ID: 29875409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.
    Palmieri M; Kim HN; Gomez-Acevedo H; Que X; Tsimikas S; Jilka RL; Manolagas SC; Witztum JL; Ambrogini E
    J Bone Miner Res; 2021 Jan; 36(1):170-185. PubMed ID: 32990984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.
    Yeang C; Hasanally D; Que X; Hung MY; Stamenkovic A; Chan D; Chaudhary R; Margulets V; Edel AL; Hoshijima M; Gu Y; Bradford W; Dalton N; Miu P; Cheung DY; Jassal DS; Pierce GN; Peterson KL; Kirshenbaum LA; Witztum JL; Tsimikas S; Ravandi A
    Cardiovasc Res; 2019 Jan; 115(1):179-189. PubMed ID: 29850765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice.
    Palmieri M; Almeida M; Nookaew I; Gomez-Acevedo H; Joseph TE; Que X; Tsimikas S; Sun X; Manolagas SC; Witztum JL; Ambrogini E
    Aging Cell; 2021 Aug; 20(8):e13442. PubMed ID: 34278710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.
    Binder CJ; Hartvigsen K; Chang MK; Miller M; Broide D; Palinski W; Curtiss LK; Corr M; Witztum JL
    J Clin Invest; 2004 Aug; 114(3):427-37. PubMed ID: 15286809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish.
    Fang L; Green SR; Baek JS; Lee SH; Ellett F; Deer E; Lieschke GJ; Witztum JL; Tsimikas S; Miller YI
    J Clin Invest; 2011 Dec; 121(12):4861-9. PubMed ID: 22105168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies.
    Tsiantoulas D; Perkmann T; Afonyushkin T; Mangold A; Prohaska TA; Papac-Milicevic N; Millischer V; Bartel C; Hörkkö S; Boulanger CM; Tsimikas S; Fischer MB; Witztum JL; Lang IM; Binder CJ
    J Lipid Res; 2015 Feb; 56(2):440-8. PubMed ID: 25525116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
    Choi SH; Gonen A; Diehl CJ; Kim J; Almazan F; Witztum JL; Miller YI
    Autophagy; 2015; 11(5):785-95. PubMed ID: 25946330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.
    Briley-Saebo KC; Shaw PX; Mulder WJ; Choi SH; Vucic E; Aguinaldo JG; Witztum JL; Fuster V; Tsimikas S; Fayad ZA
    Circulation; 2008 Jun; 117(25):3206-15. PubMed ID: 18541740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
    Atkinson C; Qiao F; Yang X; Zhu P; Reaves N; Kulik L; Goddard M; Holers VM; Tomlinson S
    Circulation; 2015 Mar; 131(13):1171-80. PubMed ID: 25825397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
    Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
    Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SERUM LEVELS OF ANTIBODIES AGAINST OXIDATION-SPECIFIC EPITOPES ARE DECREASED IN PATIENTS WITH RETINAL VEIN OCCLUSION.
    Posch-Pertl L; Weger M; Pinter-Hausberger S; List W; Posch F; Wedrich A; Michelitsch K; Kozma MO; Woltsche N; Binder CJ
    Retina; 2021 Jun; 41(6):1193-1201. PubMed ID: 33136978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice.
    Liu Y; Almeida M; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL
    Am J Physiol Endocrinol Metab; 2016 May; 310(9):E762-73. PubMed ID: 26956187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein.
    Turunen SP; Kummu O; Harila K; Veneskoski M; Soliymani R; Baumann M; Pussinen PJ; Hörkkö S
    PLoS One; 2012; 7(4):e34910. PubMed ID: 22496875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An atherosclerotic plaque-targeted single-chain antibody for MR/NIR-II imaging of atherosclerosis and anti-atherosclerosis therapy.
    Zhang L; Xue S; Ren F; Huang S; Zhou R; Wang Y; Zhou C; Li Z
    J Nanobiotechnology; 2021 Sep; 19(1):296. PubMed ID: 34583680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The OSE complotype and its clinical potential.
    Alic L; Binder CJ; Papac-Milicevic N
    Front Immunol; 2022; 13():1010893. PubMed ID: 36248824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Autoimmune IgM Antibody Attenuates Atherosclerosis in IgM Deficient Low-Fat Diet-Fed, but Not Western Diet-Fed
    Cherepanova OA; Srikakulapu P; Greene ES; Chaklader M; Haskins RM; McCanna ME; Bandyopadhyay S; Ban B; Leitinger N; McNamara CA; Owens GK
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):206-219. PubMed ID: 31645128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.
    Chou MY; Fogelstrand L; Hartvigsen K; Hansen LF; Woelkers D; Shaw PX; Choi J; Perkmann T; Bäckhed F; Miller YI; Hörkkö S; Corr M; Witztum JL; Binder CJ
    J Clin Invest; 2009 May; 119(5):1335-49. PubMed ID: 19363291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.